Literature DB >> 35414808

Association SOD2 and PON1 Gene Polymorphisms with Polycystic Ovary Syndrome in Saudi Women.

Afrah F Alkhuriji1, Suliman Y AlOmar1, Zainb A Babay2, Manal F El-Khadragy3,4, Amani R Alsharidah1, Alharbi Hanan1, Alaa A Alnafjan1, Lamjed Mansour1.   

Abstract

Polycystic ovary syndrome (PCOS) is a considered one of the most common female disorders associated with reproductive, metabolic, and psychological problems. The etiology of PCOS is still not yet disclosed; however, evidence for a genetic basis has been reported. In this study, we investigate the associations between superoxide dismutase 2 (SOD2) (rs4880) and paraoxonase 1 (PON1) (rs705379) polymorphisms in PCOS in Saudi women. The study included 99 females with PCOS and 98 healthy women as a control. Single nucleotide polymorphisms (SNPs) of promoter regions were determined using TaqMan genotyping assays. Regarding the polymorphism at SOD2 (rs4880), the CC, CT, and TT genotypes were present at rates of 32, 61, and 7% in PCOS patients, and 47, 43, and 10% in controls, respectively. The frequency of the CT genotype in PCOS patients (0.61) was significantly higher than in controls (0.43) (OR = 2.05, CI: 1.16-3.61; p = 0.015). The wild homozygous genotype (CC) with the phenotype alanine appears to confer protection against the disease compared to molecules sharing at least one valine (genotypes, CT + TT). Regarding the polymorphism at PON1 (rs705379), the rates of CC, CT, and TT genotypes were 34, 50, and 16% in PCOS patients and 33, 63, and 2% in controls, respectively. The rate of the TT genotype in PCOS patients was significantly higher than that in controls (p = 0.0058). SOD2 and PON1 polymorphisms may be genetic factors that affect the occurrence of PCOS in Saudi females.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Mitochondrial superoxide dismutase 2; Paraoxonase 1; Polycystic ovary syndrome; Polymorphism

Year:  2021        PMID: 35414808      PMCID: PMC8928176          DOI: 10.1159/000519527

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  37 in total

1.  Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS?

Authors:  Polat Dursun; Ezgi Demirtaş; Ahmet Bayrak; Hakan Yarali
Journal:  Hum Reprod       Date:  2005-09-09       Impact factor: 6.918

2.  The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women.

Authors:  José L San Millán; Francisco Alvarez-Blasco; Manuel Luque-Ramírez; José I Botella-Carretero; Héctor F Escobar-Morreale
Journal:  Hum Reprod       Date:  2006-07-31       Impact factor: 6.918

3.  Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism.

Authors:  Sara Deakin; Ilia Leviev; Monica Gomaraschi; Laura Calabresi; Guido Franceschini; Richard W James
Journal:  J Biol Chem       Date:  2001-11-28       Impact factor: 5.157

4.  [The -108 C/T polymorphism in paraoxonase 1 gene in Chinese patients with polycystic ovary syndrome].

Authors:  Feng Zhang; Hong-Wei Liu; Ping Fan; Huai Bai; Qi Song
Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban       Date:  2011-01

Review 5.  Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.

Authors:  Mike Mackness; Bharti Mackness
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

6.  The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.

Authors:  S L Primo-Parmo; R C Sorenson; J Teiber; B N La Du
Journal:  Genomics       Date:  1996-05-01       Impact factor: 5.736

7.  Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease.

Authors:  S Shimoda-Matsubayashi; H Matsumine; T Kobayashi; Y Nakagawa-Hattori; Y Shimizu; Y Mizuno
Journal:  Biochem Biophys Res Commun       Date:  1996-09-13       Impact factor: 3.575

Review 8.  Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review.

Authors:  Arundhati Bag; Niladri Bag
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

Review 9.  Polycystic ovary syndrome.

Authors:  Ricardo Azziz; Enrico Carmina; ZiJiang Chen; Andrea Dunaif; Joop S E Laven; Richard S Legro; Daria Lizneva; Barbara Natterson-Horowtiz; Helena J Teede; Bulent O Yildiz
Journal:  Nat Rev Dis Primers       Date:  2016-08-11       Impact factor: 52.329

10.  Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome.

Authors:  Naci Kemal Kuşçu; Ahmet Var
Journal:  Acta Obstet Gynecol Scand       Date:  2009       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.